MENU
PTCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PTC Therapeutics (PTCT) Ownership - Who owns PTC Therapeutics?
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.81B
P/E Ratio
N/A
Total Cash
1.14B
Projected Growth
N/A
Total Debt
2.47B
Revenue
806.78M
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash/Share
14.45
Total Debt/Equity
0.01
Revenue/Share
10.50 USD as % of share price
Fundamentals
PTCT
Capitalization
3.82B
P/E Ratio
N/A
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash
1.14B
Total Cash/Share
14.45
Total Debt
2.47B
Total Debt/Equity
0.01
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
10.50%
Revenue
807M
ROE
N/A
Book Value
-1.1B
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-4.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
77K
Current Ratio
2.35
Current Revenue Per Employee
227020.23
Dividends Per Share - Security
N/A
EBITDA
-120.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.36
Revenue To Assets
-20.18
Shares Held By Institutions
7.74B
Shares Outstanding - Current
78.9M
Total Liabilities
2.8B
Total Volume MTD
N/A
Value
-1
Gain YTD
7.156
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com